Hydrochloric Acid

Hydrochloric Acid

SCHEMBL56683

CC(C)Cc1cccc(OC(C)OC(C)[N+](C)(C)Cc2ccccc2)c1CC(C)C.[Cl-]

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
GABRA1 P14867 1/20 0.32
GABRB2 P47870 1/20 0.32
PTGER1 P34995 1/20 0.31
PTGER4 P35408 1/20 0.31
PTGER3 P43115 1/20 0.31
PTGER2 P43116 1/20 0.31
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL9229151 0.99 KDM4E (0.33) KDM4EALDH1A1TDP1GABRA1GABRB2
SCHEMBL5360957 0.99 GABRA1 (0.33) KDM4EALDH1A1TDP1GABRA1GABRB2
Hydrochloric Acid SCHEMBL6662799 0.91 KDM4E (0.36) KDM4EALDH1A1TDP1GABRA1GABRB2
SCHEMBL25349713 0.90 GABRA1 (0.35) KDM4EALDH1A1TDP1GABRA1GABRB2
Hydrochloric Acid SCHEMBL8958601 0.90 KDM4E (0.37) KDM4EALDH1A1TDP1GABRA1GABRB2
SCHEMBL1013749 0.89 GABRA1 (0.36) KDM4EALDH1A1TDP1GABRA1GABRB2
Hydrochloric Acid SCHEMBL1843352 0.82 ACHE (0.32) GABRA1GABRB2
Hydrochloric Acid SCHEMBL11142161 0.80 GABRA1 (0.32) ALDH1A1GABRA1GABRB2
Hydrochloric Acid SCHEMBL11238931 0.78 KDM4E (0.31) KDM4EALDH1A1TDP1GABRA1GABRB2
SCHEMBL11863963 0.77 GABRA1 (0.31) GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109312218-B Determining residual friction reducer concentration for subterranean treatment fluids 哈利伯顿能源服务公司 2021-08-31 CN claimed
US-20110245784-A1 ANTI-INFECTIVE COMPOSITIONS, METHODS AND SYSTEMS FOR TREATING PATHOGEN-INDUCED DISORDERED TISSUES QUADEX PHARMACEUTICALS, LLC (US) 2011-10-06 US claimed
EP-2313026-A1 ACTIVE DELIVERY SYSTEM FORMULATIONS Castle Beach, L.L.C. (US) 2011-04-27 EP claimed
WO-2010019680-A1 ACTIVE DELIVERY SYSTEM FORMULATIONS HOMOLA ANDREW M (US) 2010-02-18 WO claimed
US-20100040565-A1 ACTIVE DELIVERY SYSTEMS FORMULATIONS Castle Beach, LLC (US) 2010-02-18 US claimed
EP-0805672-B1 METHODS, COMPOSITIONS, AND DENTAL DELIVERY SYSTEMS FOR THE PROTECTION OF THE SURFACES OF TEETH HOMOLA ANDREW M (US) 2004-08-25 EP claimed
US-5665333-A Methods, compositions, and dental delivery systems for the protection of the surfaces of teeth PROVSEAL LLC 1997-09-09 US claimed
US-11633341-B2 Dental varnishes that release specifically targeted antimicrobial peptides and/or fluoride C3 JIAN, LLC (US) 2023-04-25 US disclosed
US-11628136-B2 Oral care compositions comprising at least one phosphate/acrylate copolymer and at least one cationic active ingredient COLGATE-PALMOLIVE COMPANY (US) 2023-04-18 US disclosed
CN-115362247-A Aqueous laundry treatment composition 联合利华知识产权控股有限公司 2022-11-18 CN disclosed
CN-109789384-B Improvements in or relating to organic compounds 奇华顿股份有限公司 2022-06-07 CN disclosed
CN-113557038-A Improved method and composition for surface treatment 史蒂文·克里茨勒 2021-10-26 CN disclosed
CN-108472617-B Microcapsules comprising a polyester-urethane shell and a hydrophilic core material 巴斯夫欧洲公司 2021-09-14 CN disclosed
US-3946108-A CLARITY, DEGASSING, SUSPENDING AIR OR NITROGEN BUBBLES COLGATE-PALMOLIVE COMPANY (US) 1976-03-23 US disclosed
US-3944661-A MOTHER OF PEARL COLGATE-PALMOLIVE COMPANY (US) 1976-03-16 US disclosed
US-3943240-A Toothpaste COLGATE-PALMOLIVE COMPANY (US) 1976-03-09 US disclosed
US-3937805-A METHOD OF MAKING DENTIFRICE COMPOSITIONS CONTAINING INSOLUBILIZED SALTS OF 1,6-DI-(P-CHLOROPHENYL BIGUANIDO) HEXANE COLGATE-PALMOLIVE COMPANY (US) 1976-02-10 US disclosed
US-3937321-A Toothpaste COLGATE-PALMOLIVE COMPANY (US) 1976-02-10 US disclosed
US-3937804-A TOOTHPASTE COLGATE-PALMOLIVE COMPANY (US) 1976-02-10 US disclosed
US-3934000-A SODIUM CARBOXYMETHYL CELLULOSE, POLYOXYETHYLENE GLYCOL, SILICA, ABRASIVE COLGATE-PALMOLIVE COMPANY (US) 1976-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100040565-A1 ACTIVE DELIVERY SYSTEMS FORMULATIONS LIPA, MMP7, CTSA KDM4E 4420/4885ALDH1A1 1412/4885TDP1 2046/4885
US-11628136-B2 Oral care compositions comprising at least one phosphate/acrylate copolymer and at least one cationic active ingredient HDAC1, SLC30A5, HDAC11 KDM4E 4575/4885ALDH1A1 1847/4885TDP1 1990/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.